Home Merck Sues Actavis Unit Over Patent for Generic NuvaRing
 

Keywords :   


Merck Sues Actavis Unit Over Patent for Generic NuvaRing

2013-12-25 00:26:03| Biotech - Topix.net

Merck & Co. sued Actavis Plc's Warner Chilcott unit seeking to block sales of a generic version of NuvaRing, a contraceptive with estimated annual sales of more than $664 million.

Tags: unit patent generic merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Atlantic Tropical Weather Outlook
18.06Potential Tropical Cyclone One Public Advisory Number 1A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Could brain-like computers be a 'competition killer'?
18.06Low investment blocking UK growth, says think tank
18.06Eastern North Pacific Tropical Weather Outlook
18.06Boeing boss admits culture 'far from perfect'
More »